Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

Clinical trial NCT04701164 · COMPLETED

Trial details

NCT number: NCT04701164
Sponsor: Annexon, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Guillain-Barre Syndrome

Start date: 2020-12-17
Primary completion: 2024-04-20
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.